Scholar Rock Holding (SRRK) Treasury Shares (2017 - 2026)
Scholar Rock Holding (SRRK) recorded quarterly Treasury Shares of $3.8 million in Q1 2026, up 16.77% quarter-over-quarter from $3.3 million in Q4 2025, and up 3.59% on a YoY basis from $3.7 million in Q1 2025.
Scholar Rock Holding (SRRK) Treasury Shares (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Treasury Shares history runs 10 years deep, the most recent figure standing at $3.8 million for Q1 2026.
- In Q1 2026, Treasury Shares rose 3.59% year-over-year to $3.8 million; the TTM figure through Mar 2026 stood at $3.8 million (up 3.59% YoY), while the FY2025 annual figure was $3.3 million, down 5.81% from the prior year.
- Treasury Shares was $3.8 million for Q1 2026 at Scholar Rock Holding, up from $3.3 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $3.8 million in Q1 2026 to a low of $1.0 million in Q1 2022.
- Historically, Treasury Shares has averaged $2.7 million across 5 years, with a median of $3.0 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Treasury Shares soared 3003.62% in 2022, then retreated 5.81% in 2025.
- A 5-year view of Treasury Shares shows it stood at $1.7 million in 2022, then grew by 25.31% to $2.1 million in 2023, then jumped by 66.86% to $3.5 million in 2024, then retreated by 5.81% to $3.3 million in 2025, then gained by 16.77% to $3.8 million in 2026.
- The last three Treasury Shares figures came in at $3.8 million (Q1 2026), $3.3 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Scholar Rock Holding | 6.03 Bn | 5.55 Bn | - | 3.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.83 Mn |
| Mar 31, 2026 | 3.83 Mn |
| Dec 31, 2025 | 3.28 Mn |
| Dec 31, 2025 | 3.28 Mn |
| Sep 30, 2025 | 3.54 Mn |
| Sep 30, 2025 | 3.54 Mn |
| Jun 30, 2025 | 3.55 Mn |
| Jun 30, 2025 | 3.55 Mn |
| Mar 31, 2025 | 3.70 Mn |
| Mar 31, 2025 | 3.70 Mn |
| Dec 31, 2024 | 3.49 Mn |
| Dec 31, 2024 | 3.49 Mn |
| Sep 30, 2024 | 3.39 Mn |
| Sep 30, 2024 | 3.39 Mn |
| Jun 30, 2024 | 2.98 Mn |
| Jun 30, 2024 | 2.98 Mn |
| Mar 31, 2024 | 3.09 Mn |
| Mar 31, 2024 | 3.09 Mn |
| Dec 31, 2023 | 2.09 Mn |
| Dec 31, 2023 | 2.09 Mn |